ITERUM THERAPEUTICS PLC's ticker is ITRM and the CUSIP is G6333L101. A total of 13 filers reported holding ITERUM THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,169,000 | +42.6% | 1,538,316 | 0.0% | 0.17% | +48.7% |
| Q4 2020 | $1,521,000 | -5.8% | 1,538,316 | 0.0% | 0.12% | -19.3% |
| Q3 2020 | $1,615,000 | -11.8% | 1,538,316 | 0.0% | 0.14% | -9.9% |
| Q2 2020 | $1,831,000 | -56.1% | 1,538,316 | 0.0% | 0.16% | -66.0% |
| Q1 2020 | $4,169,000 | -39.8% | 1,538,316 | 0.0% | 0.47% | -59.3% |
| Q4 2019 | $6,922,000 | -22.0% | 1,538,316 | 0.0% | 1.16% | -58.2% |
| Q3 2019 | $8,876,000 | -16.1% | 1,538,316 | 0.0% | 2.78% | +2.3% |
| Q2 2019 | $10,584,000 | -13.1% | 1,538,316 | 0.0% | 2.71% | -7.5% |
| Q1 2019 | $12,186,000 | +58.1% | 1,538,316 | 0.0% | 2.93% | +47.5% |
| Q4 2018 | $7,707,000 | -25.2% | 1,538,316 | 0.0% | 1.99% | +5.4% |
| Q3 2018 | $10,307,000 | -37.2% | 1,538,316 | 0.0% | 1.89% | -44.5% |
| Q2 2018 | $16,414,000 | – | 1,538,316 | – | 3.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,538,316 | $10,307,000 | 1.89% |
| New Leaf Venture Partners, L.L.C. | 1,456,303 | $9,648,000 | 1.76% |
| Sofinnova Investments, Inc. | 1,726,514 | $11,438,000 | 1.02% |
| Cormorant Asset Management, LP | 476,968 | $3,196,000 | 0.21% |
| Granahan Investment Management | 250,717 | $1,661,000 | 0.09% |
| TIVERTON ASSET MANAGEMENT LLC | 140,448 | $941,000 | 0.05% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 100,000 | $670,000,000 | 0.02% |
| Neuburgh Advisers LLC | 61,676 | $413,000 | 0.01% |
| Flinton Capital Management LLC | 50,792 | $340,000 | 0.01% |
| Tyers Asset Management LLC | 39,908 | $268,000 | 0.01% |